ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

163 Episodo

1. ACCEL Lite: Help Me Breathe! Differentiating HFpEF From Other Causes of Dyspnea

   Publicado: 13/6/2023
2. ACCEL Lite: Clinical Manifestations of RV Failure and Management

   Publicado: 6/6/2023
3. ACCEL Lite: Beyond the Blips and Bumps: Outpatient EP for the General Cardiologist

   Publicado: 23/5/2023
4. ACCEL Lite: Managing Chest Pain in the ER: Takeaways from the 2022 ACC ECDP

   Publicado: 16/5/2023
5. ACCEL Lite: Doc, My Watch Says I Have AF: Integrating Consumer-Facing Device Findings into Clinical Care

   Publicado: 9/5/2023
6. ACCEL Lite: Management of INOCA and MINOCA: What Do We Know and How Are We Doing?

   Publicado: 4/5/2023
7. ACCEL Lite: The Echo Shows PH: What is the Differential, What are the Therapeutic Options, and When to Refer to a PH Center

   Publicado: 2/5/2023
8. ACCEL Lite: Optimizing the Care of ASCVD Patients with T2DM

   Publicado: 25/4/2023
9. ACCEL Lite: Revascularization of Stable Ischemic Heart Disease in the Era of COURAGE, ISCHEMIA, and ORBITA

   Publicado: 18/4/2023
10. ACCEL Lite: Long-Term Secondary Prevention After PCI or MI: Aspirin, Clopidogrel, DAPT or DPI?

    Publicado: 13/4/2023
11. ACCEL Lite: Understanding the Basics of HF-rEF and Work Up

    Publicado: 11/4/2023
12. ACCEL Lite: ISCHEMIA-EXTENDed – Follow-Up Interim Report

    Publicado: 4/4/2023
13. ACCEL Lite: ACC.23 Late-Breaker: Bempedoic Acid and Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk

    Publicado: 28/3/2023
14. ACCEL Lite: When Lifestyle Isn't Enough: Surgical vs. Pharmacological Approaches for Obesity

    Publicado: 21/3/2023
15. ACCEL Lite: ACC.23 Late-Breaker: Vigorous Exercise in Individuals with Hypertrophic Cardiomyopathy: Primary Results of the LIVE-HCM Study

    Publicado: 14/3/2023
16. ACCEL Lite: Statins To Prevent The Cardiotoxicity From Anthracyclines: The STOP-CA Trial

    Publicado: 7/3/2023
17. ACCEL Lite: From JACC: CACS Improves Risk Prediction in Patients with Suspected Obstructive CAD

    Publicado: 28/2/2023
18. ACCEL Lite: PRECISE – Comparison of a Precision Care Strategy with Usual Testing to Guide Management of Stable Patients With Suspected CAD

    Publicado: 21/2/2023
19. ACCEL Lite: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in HFrEF

    Publicado: 14/2/2023
20. PROMINENT – A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of CVD

    Publicado: 7/2/2023